Myriad Genetics | MYGN - Cost Of Sales

Stock Price
4.61
Daily Change
-0.16 -3.35%
Monthly
-9.96%
Yearly
-42.01%
Q2 Forecast
4.61

Myriad Genetics reported $63M in Cost of Sales for its fiscal quarter ending in December of 2025.





Cost Of Sales Change Date
Agilent USD 852M 19M Dec/2025
Becton, Dickinson and Co. USD 2.84B 2.35B Dec/2025
Bio-Rad Laboratories USD 309.6M 3.3M Sep/2025
Bruker USD 528M 46.9M Dec/2025
Danaher USD 2.87B 342M Dec/2025
Hologic USD 463.7M 5.1M Dec/2025
Illumina USD 400M 49M Dec/2025
J&J USD 7.97B 689M Dec/2025
Mettler Toledo International USD 473.97M 33.71M Dec/2025
Myriad Genetics USD 63M 1.1M Dec/2025
OraSure Technologies USD 15.43M 113K Dec/2025
Pacific Biosciences Of California USD 28.9M 10M Dec/2025
Quest Diagnostics USD 1.93B 27M Dec/2025
Quidel USD 448.8M 1.21B Dec/2025
Repligen USD 94.08M 5.79M Dec/2025
Revvity USD 350.4M 26.05M Dec/2025
Standard Biotools USD 12.41M 2.34M Dec/2025
Thermo Fisher Scientific USD 7.58B 674M Dec/2025
Veracyte USD 39.28M 1.93M Dec/2025
Waters USD 374.94M 47.13M Dec/2025